艾滋病合并马尔尼菲篮状菌及组织胞浆菌2例临床病理分析
Clinical and Pathological Analysis of Two Cases of AIDS Complicated with Talaromyces marneffei and Histoplasma capsulatum
DOI: 10.12677/acm.2025.1582299, PDF,   
作者: 梁 娟*, 屠云娇, 张 铭, 谭永兴:云南省滇南中心医院(红河州第一人民医院)病理科,云南 蒙自;王巧凤:玉溪市第一人民医院感染科,云南 玉溪
关键词: 艾滋病马尔尼菲篮状菌组织胞浆菌临床病理特征AIDS Talaromyces marneffei Histoplasma capsulatum Clinical and Pathological Characteristics
摘要: 目的:分析艾滋病合并马尔尼菲篮状菌及组织胞浆菌的临床资料、病理表现,探讨其诊断、发病机制和临床治疗方案。方法:回顾性分析2例艾滋病合并马尔尼菲篮状菌及组织胞浆菌的临床病理学特征并复习相关文献。结果:2例患者因不同临床表现入院,实验室检查均提示艾滋病并马尔尼菲篮状菌感染,病理活检提示马尔尼菲篮状菌及组织胞浆菌感染。结论:艾滋病合并马尔尼菲篮状菌及组织胞浆菌感染临床表现复杂多样,诊断和治疗难度较大,及时进行病原学检测及病理学活检,为早期诊断和治疗提供有力支持。
Abstract: Objective: To analyze the clinical data and pathological manifestations of AIDS complicated with Talaromyces marneffei and Histoplasma capsulatum, and to explore its diagnosis, pathogenesis and clinical treatment. Methods: The clinicopathological characteristics of 2 cases of AIDS complicated with Talaromyces marneffei and Histoplasma capsulatum were retrospectively analyzed and relevant literature was reviewed. Results: The 2 patients were admitted to the hospital due to different clinical manifestations. Laboratory tests showed AIDS complicated with Talaromyces marneffei infection, and pathological biopsy showed Talaromyces marneffei and Histoplasma capsulatum infection. Conclusion: The clinical manifestations of AIDS complicated with Talaromyces marneffei and Histoplasma capsulatum infection are complex and diverse, and the diagnosis and treatment are difficult. Timely etiological detection and pathological biopsy provide strong support for early diagnosis and treatment.
文章引用:梁娟, 王巧凤, 屠云娇, 张铭, 谭永兴. 艾滋病合并马尔尼菲篮状菌及组织胞浆菌2例临床病理分析[J]. 临床医学进展, 2025, 15(8): 796-802. https://doi.org/10.12677/acm.2025.1582299

参考文献

[1] Pruksaphon, K., Intaramat, A., Ratanabanangkoon, K., Nosanchuk, J.D., Vanittanakom, N. and Youngchim, S. (2018) Development and Characterization of an Immunochromatographic Test for the Rapid Diagnosis of Talaromyces (Penicillium) marneffei. PLOS ONE, 13, e0195596. [Google Scholar] [CrossRef] [PubMed]
[2] Ning, C., Lai, J., Wei, W., Zhou, B., Huang, J., Jiang, J., et al. (2018) Accuracy of Rapid Diagnosis of Talaromyces marneffei: A Systematic Review and Meta-Analysis. PLOS ONE, 13, e0195569. [Google Scholar] [CrossRef] [PubMed]
[3] Pongpom, M., Vanittanakom, P., Nimmanee, P., Cooper, C.R. and Vanittanakom, N. (2017) Adaptation to Macrophage Killing by Talaromyces marneffei. Future Science OA, 3, FSO215. [Google Scholar] [CrossRef] [PubMed]
[4] Wang, Y., Cheng, J., Ding, H., Lin, X., Chen, G., Zhou, M., et al. (2018) Study on the Clinical Features and Prognosis of Penicilliosis marneffei without Human Immunodeficiency Virus Infection. Mycopathologia, 183, 551-558. [Google Scholar] [CrossRef] [PubMed]
[5] Bulterys, P.L., Le, T., Quang, V.M., Nelson, K.E. and Lloyd-Smith, J.O. (2013) Environmental Predictors and Incubation Period of Aids-Associated Penicillium marneffei Infection in Ho Chi Minh City, Vietnam. Clinical Infectious Diseases, 56, 1273-1279. [Google Scholar] [CrossRef] [PubMed]
[6] Armstrong-James, D., Meintjes, G. and Brown, G.D. (2014) A Neglected Epidemic: Fungal Infections in HIV/Aids. Trends in Microbiology, 22, 120-127. [Google Scholar] [CrossRef] [PubMed]
[7] Shi, M., Lin, J., Wei, W., Qin, Y., Meng, S., Chen, X., et al. (2022) Machine Learning-Based In-Hospital Mortality Prediction of HIV/AIDS Patients with Talaromyces marneffei Infection in Guangxi, China. PLOS Neglected Tropical Diseases, 16, e0010388. [Google Scholar] [CrossRef] [PubMed]
[8] Meng, S., Tang, Q., Xie, Z., Wu, N., Qin, Y., Chen, R., et al. (2022) Spectrum and Mortality of Opportunistic Infections among HIV/AIDS Patients in Southwestern China. European Journal of Clinical Microbiology & Infectious Diseases, 42, 113-120. [Google Scholar] [CrossRef] [PubMed]
[9] Jiang, J., Meng, S., Huang, S., Ruan, Y., Lu, X., Li, J.Z., et al. (2019) Effects of Talaromyces marneffei Infection on Mortality of HIV/AIDS Patients in Southern China: A Retrospective Cohort Study. Clinical Microbiology and Infection, 25, 233-241. [Google Scholar] [CrossRef] [PubMed]
[10] Pang, W., Shang, P., Li, Q., Xu, J., Bi, L., Zhong, J., et al. (2018) Prevalence of Opportunistic Infections and Causes of Death among Hospitalized HIV-Infected Patients in Sichuan, China. The Tohoku Journal of Experimental Medicine, 244, 231-242. [Google Scholar] [CrossRef] [PubMed]
[11] Qiu, Y., Zhang, J., Pan, M., Zeng, W., Tang, S. and Tan, C. (2019) Determinants of Prognosis in Talaromyces marneffei Infections with Respiratory System Lesions. Chinese Medical Journal, 132, 1909-1918. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, Y.F., Xu, H.F., Han, Z.G., Zeng, L., Liang, C.Y., Chen, X., et al. (2015) Serological Surveillance for Penicillium Marneffei Infection in HIV-Infected Patients during 2004-2011 in Guangzhou, China. Clinical Microbiology and Infection, 21, 484-489. [Google Scholar] [CrossRef] [PubMed]
[13] Limper, A.H., Adenis, A., Le, T. and Harrison, T.S. (2017) Fungal Infections in HIV/Aids. The Lancet Infectious Diseases, 17, e334-e343. [Google Scholar] [CrossRef] [PubMed]
[14] Adenis, A.A., Valdes, A., Cropet, C., McCotter, O.Z., Derado, G., Couppie, P., et al. (2018) Burden of HIV-Associated Histoplasmosis Compared with Tuberculosis in Latin America: A Modelling Study. The Lancet Infectious Diseases, 18, 1150-1159. [Google Scholar] [CrossRef] [PubMed]
[15] Pamnani, R., Rajab, J., Githang’a, J. and Kasmani, R. (2010) Disseminated Histoplasmosis Diagnosed on Bone Marrow Aspirate Cytology: Report of Four Cases. East African Medical Journal, 86, 102-105. [Google Scholar] [CrossRef] [PubMed]
[16] Couppié, P., Herceg, K., Bourne-Watrin, M., Thomas, V., Blanchet, D., Alsibai, K.D., et al. (2019) The Broad Clinical Spectrum of Disseminated Histoplasmosis in HIV-Infected Patients: A 30 Years’ Experience in French Guiana. Journal of Fungi, 5, Article 115. [Google Scholar] [CrossRef] [PubMed]
[17] Wheat, J. (1995) Endemic Mycoses in AIDS: A Clinical Review. Clinical Microbiology Reviews, 8, 146-159. [Google Scholar] [CrossRef] [PubMed]
[18] Mittal, J., Ponce, M.G., Gendlina, I. and Nosanchuk, J.D. (2018) Histoplasma capsulatum: Mechanisms for Pathogenesis. In: Rodrigues, M., Ed., Fungal Physiology and Immunopathogenesis, Springer, 157-191. [Google Scholar] [CrossRef] [PubMed]
[19] Allen, H.L. and Deepe, G.S. (2006) B Cells and CD4CD8 T Cells Are Key Regulators of the Severity of Reactivation Histoplasmosis. The Journal of Immunology, 177, 1763-1771. [Google Scholar] [CrossRef] [PubMed]